| Application no. and date | 01902590.7 (espacenet) (Federated) (European Patent Register), 20010215 | | Patent/reg. no. and date | DK/EP 1267885, 20070307 | | Publication date | 20030102 | | Priority no. and date | US 503729, 20000215, EP 00200493, 20000215 | | EP pub. no. and date |
EP 1267885 20030102 | | Effective date | | | Applicant/owner | Bayer Pharma Aktiengesellschaft, Müllerstrasse 178
13353 Berlin, DE | | Applicant ref. no. | P23364DK01 | | Inventor | NIESCHLAG, Eberhard, Gremmer Dorderweg 91
48197 Münster, DE,
KAMISCHKE, Axel, Nimrodweg 10
48165 Münster, DE,
RUEBIG, Alexander, Sandhauser Strasse 113 A
13505 Berlin, DE,
SCHILLINGER, Ekkerhard, Im Amseltal 50
13465 Berlin, DE,
OETTEL, Michael, Beethovenstrasse 30
07743 Jena, DE,
HABENICHT, Ursula-Friederike, Im Schönower Park 1
14167 Berlin, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/57 (2006.01) , A61P 15/16 (2006.01) | | Title | Formulering til svangerskabsforebyggelse hos mænd, hvilken formulering indeholder norethisteron og testoteronundecanoat | | Int. application no. | IB2001000188 | | Int. publication no. | WO2001060376 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
